Lipella Pharmaceuticals Inc. (LIPO) SEC Filings — 2025

Filings

• Lipella's Q3 Loss Narrows, But Cash Dwindles Amid Zero Revenue — 10-Q · Nov 14, 2025
• Lipella Pharmaceuticals Announces Board and Officer Changes — 8-K · Oct 21, 2025
• Lipella Pharmaceuticals Inc. Announces Board and Executive Changes — 8-K · Oct 9, 2025
• Lipella Pharmaceuticals Inc. 8-K Filing — 8-K · Sep 18, 2025
• Lipella's Losses Widen Amid Rising R&D, Nasdaq Suspension Hits Shares — 10-Q · Aug 14, 2025
• Lipella Pharmaceuticals Files 8-K — 8-K · Jun 25, 2025
• Lipella Pharmaceuticals Faces Delisting Concerns — 8-K · Jun 20, 2025
• Lipella Pharmaceuticals Files 8-K — 8-K · Jun 16, 2025
• Lipella Pharmaceuticals Faces Delisting Concerns — 8-K · May 16, 2025
• Lipella Pharmaceuticals Files 8-K — 8-K · May 15, 2025
• Lipella Pharmaceuticals Q1 2025: Grant Revenue Soars — 10-Q · May 14, 2025
• Lipella Pharmaceuticals to Acquire Immuno-Oncology Therapeutics — 8-K · Apr 14, 2025
• Lipella Pharmaceuticals Files 8-K on Corporate Changes — 8-K · Apr 9, 2025
• Lipella Pharmaceuticals Enters Material Definitive Agreement — 8-K · Apr 7, 2025
• Lipella Pharmaceuticals Files 2024 10-K — 10-K · Mar 28, 2025
• Lipella Pharmaceuticals Files 8-K with Material Agreement — 8-K · Mar 18, 2025
• Lipella Pharmaceuticals Files 8-K: Material Agreement & Equity Sales — 8-K · Mar 11, 2025
• Lipella Pharmaceuticals Files 8-K: Material Agreement & Equity Sales — 8-K · Mar 3, 2025
• Lipella Pharmaceuticals Files 8-K for Material Agreement — 8-K · Feb 24, 2025
• Lipella Pharmaceuticals Files 8-K — 8-K · Feb 11, 2025
• Lipella Pharmaceuticals Faces Delisting Concerns — 8-K · Jan 13, 2025
• Lipella Pharmaceuticals Files 8-K on Agreements and Equity Sales — 8-K · Jan 6, 2025